Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...

Fatty liver disease is a common health issue. It is often linked to weight and lifestyle. Early detection is key to prevent ...

Editorial: The health department rolling out jabs to patients who struggle with their weight must be a moment to rethink our approach to childhood obesity, so often the precursor to a lifetime of poor ...

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and that this effect is independent of weight loss,” the researchers concluded ...

Weight loss drugs help manage blood sugar levels by mimicking two important hormones GLP-1 (glucagon-like peptide-1) and GIP ...

A large study led by researchers at Case Western Reserve University suggests that semaglutide—a drug already popular for ...

Dr. Teresa LaMasters, who leads the American Society for Metabolic and Bariatric Surgery, said this research shows how useful ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...